Teva (TEVA) Stock Statistics & Valuation Metrics

Teva has a market cap or net worth of ILA 153.59B. The enterprise value is ILA 185.30B.

Market Cap

ILA 153.59B

Enterprise Value

ILA 185.30B

Teva has 1,165,296,100 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

1,165,296,100

Owned by Insiders

―

Owned by Institutions

20.80%

Teva’s return on equity (ROE) is 0.19 and return on invested capital (ROIC) is 14.69%.

Return on Equity (ROE)

0.19

Return on Assets (ROA)

0.04

Return on Invested Capital (ROIC)

14.69%

Return on Capital Employed (ROCE)

0.16

Revenue Per Employee

560.23K

Profits Per Employee

45.80K

Employee Count

33,346

Asset Turnover

0.46

Inventory Turnover

2.85

The current PE Ratio of Teva is 92.84. Teva’s PEG ratio is -3.25.

PE Ratio

92.84

PS Ratio

2.83

PB Ratio

6.11

Price to FCF

39.39

Price to Operating Cash Flow

27.52

PEG Ratio

-3.25

In the last 12 months, Teva had revenue of 18.68B and earned 1.53B in profits. Earnings per share was 1.23.

Revenue

18.68B

Gross Profit

9.63B

Operating Income

4.28B

Pretax Income

1.34B

Net Income

1.53B

EBITDA

3.34B

Earnings Per Share (EPS)

1.23

In the last 12 months, operating cash flow was 3.14B and capital expenditures -537.95M, giving a free cash flow of 2.61B billion.

Operating Cash Flow

3.14B

Free Cash Flow

2.61B

Free Cash Flow per Share

1.06

Teva pays an annual dividend of ILA 8.50, resulting in a dividend yield of ―

Dividend Per Share

ILA 8.50

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

2.54%

Earnings Yield

1.04%

Beta

0.61

52-Week Price Change

67.54%

50-Day Moving Average

11927.60

200-Day Moving Average

10502.26

Relative Strength Index (RSI)

63.27

Average Volume (3m)

1.36M

Teva upcoming earnings date is Feb 10, 2027, TBA (Not Confirmed).

Last Earnings Date

Nov 03, 2026

Next Earnings Date

Feb 10, 2027

Ex-Dividend Date

Nov 28, 2017

Teva as a current ratio of 1.04, with Debt / Equity ratio of 219.75%

Current Ratio

1.04

Quick Ratio

0.80

Debt to Market Cap

0.46

Net Debt to EBITDA

4.14

Interest Coverage Ratio

4.23

In the past 12 months, Teva has paid -194.84M in taxes.

Income Tax

-194.84M

Effective Tax Rate

-0.15

Teva EV to EBITDA ratio is 30.23, with an EV/FCF ratio of 49.77.

EV to Sales

3.57

EV to EBITDA

30.23

EV to Free Cash Flow

49.77

EV to Operating Cash Flow

34.76

Teva has ILA 4.13B in cash and marketable securities with ILA 17.16B in debt, giving a net cash position of -ILA 13.03B billion.

Cash & Marketable Securities

ILA 4.13B

Total Debt

ILA 17.16B

Net Cash

-ILA 13.03B

Net Cash Per Share

-ILA 11.18

Tangible Book Value Per Share

-ILA 9.58

Gross margin is 53.52%, with operating margin of 10.53%, and net profit margin of 2.94%.

Gross Margin

53.52%

Operating Margin

10.53%

Pretax Margin

2.16%

Net Profit Margin

2.94%

EBITDA Margin

11.81%

EBIT Margin

6.09%

The average price target for Teva is ILA 15.73K, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target

ILA 15.73K

Price Target Upside

19.33% Upside

Analyst Consensus

Strong Buy

Analyst Count

10

Revenue Growth Forecast

-10.56%

EPS Growth Forecast

-29.51%

Smart Score

―

AI Score

63